Thrombotic thrombocytopenic purpura cases after CoronaVac raise concerns over vaccine safety
Coronavirus
Higher Education Press Nov 8 2024 The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP). This report presents two cases of TTP occurring after the administration of the inactivated vaccine CoronaVac from Sinovac Biotech, highlighting the potential association between this type of vaccine and TTP. The article also provides an analysis of TTP incidence
din zilele anterioare